India’s biotech sector works on tech, talent pool & advanced production plants to align with Viksit Bharat: Nandita Vijayasimha, Bengaluru Wednesday, February 19, 2025, 08:00 Hr ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

Biogen Inc. has agreed to pay as much as $550 million to develop and sell a drug to treat a genetic seizure disorder, the ...

Remote blood collection device maker YourBio Health is revamping its leadership team with the goal of broadening the reach of ...

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

Apple heads this list from the Management Top 250, followed by Microsoft and Walmart ...

AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...

Radiance Biopharma is heating up the ROR1 race. The U.S. biotech is paying China’s CSPC Megalith Biopharmaceutical $15 million upfront for rights to an antibody-drug conjugate, securing itself a shot ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price ...